Anti-tumor action and clinical application of proteasome inhibitor

被引：1
|
作者：
Zhou Yong-ming [2 ]
Yu Mei-xia [2 ]
Long Hui [2 ]
Huang Shi-ang [1 ]
机构：
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Stem Cell Ctr, Wuhan 430022, Peoples R China
[2] Wuhan Univ Sci & Technol, Affiliated Hosp, Dept Hematol, Wuhan 430000, Peoples R China
来源：
CHINESE JOURNAL OF CANCER RESEARCH | 2008年 / 20卷 / 02期
关键词：
proteasome inhibitor; ubiquitin-proteasome pathway; tumor;
D O I：
10.1007/s11670-008-0077-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Ubiquitin-proteasome pathway mediates the degradation of cell protein, and cell cycle, gene translation and expression, antigen presentation and inflammatory development. Proteasome inhibitor can inhibit growth and proliferation of tumor cell, induce apoptosis and reverse multipledrug resistance of tumor cell, increase the sensitivity of other chemotherapeutic drugs and radiotherapy, and is a novel class of potent anti-tumor agents.
引用
收藏
页码：77 / 84
页数：8
相关论文
共 50 条
  • [21] Application of MiniPDX® in clinical indication identification and anti-tumor drug development
    Long, Yuan
    Xie, Bin
    Chen, Hongkui
    Zhao, Shizhu
    Li, Le
    Xi, Song
    Wen, Danyi
    CANCER RESEARCH, 2023, 83 (07)
  • [22] PI-1840, a novel non-covalent and rapidly reversible proteasome inhibitor with anti-tumor activity
    Sebti, Said M.
    Kazi, Aslamuzzaman
    Ozcan, Sevil
    Tecleab, Awet G.
    Sun, Ying
    Lawrence, Harshani
    CANCER RESEARCH, 2014, 74 (19)
  • [23] Anti-tumor effects and drug interaction of proteasome inhibitor bortezomib (PS341) for gastric cancer cell
    Fujita, T.
    Washio, K.
    Ino, H.
    Murakami, M.
    Naito, M.
    Doihara, H.
    Shimizu, N.
    ANNALS OF ONCOLOGY, 2006, 17 : 49 - 49
  • [24] Anti-tumor activity of the proteasome inhibitor PS-341 in mantle cell lymphoma B cells.
    Pham, L
    Tamayo, A
    Lo, P
    Yoshimura, L
    Ford, RJ
    BLOOD, 2001, 98 (11) : 465A - 465A
  • [25] THE MODE OF ACTION OF ANTHRAMYCIN, AN ANTI-TUMOR ANTIBIOTIC
    GARNER, TF
    HURLEY, LH
    CLINICAL RESEARCH, 1980, 28 (04): : A799 - A799
  • [26] ISOPRINOSINE INCREASES THE ANTI-TUMOR ACTION OF INTERFERON
    CERUTTI, I
    CHANY, C
    SCHLUMBERGER, JF
    CANCER TREATMENT REPORTS, 1978, 62 (11): : 1971 - 1974
  • [27] MECHANISMS INVOLVED IN THE ANTI-TUMOR ACTION OF ARGININE
    RETTURA, G
    LEVENSON, SM
    SEIFTER, E
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1980, 180 (AUG): : 130 - BIOL
  • [28] Ferroptosis: A Novel Anti-tumor Action for Cisplatin
    Guo, Jipeng
    Xu, Bingfei
    Han, Qi
    Zhou, Hongxia
    Xia, Yun
    Gong, Chongwen
    Dai, Xiaofang
    Li, Zhenyu
    Wu, Gang
    CANCER RESEARCH AND TREATMENT, 2018, 50 (02): : 445 - 460
  • [29] ANTI-TUMOR ACTION OF INTERFERON - ANIMAL SYSTEMS
    CHIRIGOS, MA
    TEXAS REPORTS ON BIOLOGY AND MEDICINE, 1977, 35 : 399 - 405
  • [30] ANTI-TUMOR ACTION OF INTERFERON - ANIMAL SYSTEMS
    CHIRIGOS, MA
    TEXAS REPORTS ON BIOLOGY AND MEDICINE, 1982, 41 : 610 - 613
12345